Global Market Insights, Inc. - logo

Over-the-Counter (OTC) Drugs Market Size By Product (Analgesics, Cold, Cough & Flu Products, Weight Loss Products, Gastrointestinal Products, Skin Products, Mineral and Vitamin Supplements, Sleeping Aids, Ophthalmic Products), Industry Analysis Report, Regional Outlook U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, China, India, Japan, Australia, South Korea, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Qatar, Kuwait), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024

Published Date: December 2017 | 120 Pages | Report ID: GMI1884 Report Format: PDF

Inquiry Before Buying   Request Sample

Report Content

Chapter 1.    Methodology

1.1.   Methodology

1.1.1.  Initial data exploration

1.1.2.  Statistical model and forecast

1.1.3.  Industry insights and validation

1.1.4.  Market definition & forecast parameters

1.2.  Data sources

1.2.1.  Secondary

1.2.2.  Primary

Chapter 2.    Executive Summary

2.1.  Over-the-counter (OTC) drugs industry 3600 synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Regional trends

Chapter 3.    Over-the-counter (OTC) Drugs Industry Insights

3.1.  Industry segmentation

3.2.  Industry landscape, 2013 - 2024

3.3.  Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Pharmaceutical companies switching from Rx to OTC drugs especially in the U.S

3.3.1.2.  Growing trend of self-medication in developing economies

3.3.1.3.  Significant cost savings due to OTC drug usage in Asia pacific and Latin America

3.3.2.  Industry pitfalls & challenges

3.3.2.1.  Several concerns pertaining to incorrect diagnosis and substance abuse

3.4.  Growth potential analysis

3.4.1.  By product

3.5.  Regulatory landscape

3.5.1.  U.S.

3.5.2.  Europe

3.6.  Porter's analysis

3.7.  Competitive landscape, 2016

3.7.1.  Business overview

3.7.2.  Revenue analysis

3.7.3.  Product landscape

3.7.4.  Strategy dashboard

3.8.  PESTEL analysis

Chapter 4.    Over-the-counter (OTC) Drugs Market, By Product

4.1.  Over-the-counter (OTC) drugs market share, by product, 2016 & 2024

4.2.  Analgesics

4.2.1.  Market estimates and forecast, by region, 2013 - 2024

4.3.  Cold, cough & flu products

4.3.1.  Market estimates and forecast, by region, 2013 - 2024

4.4.  Weight loss products

4.4.1.  Market estimates and forecast, by region, 2013 - 2024

4.5.  Gastrointestinal products

4.5.1.  Market estimates and forecast, by region, 2013 - 2024

4.6.  Skin products

4.6.1.  Market estimates and forecast, by region, 2013 - 2024

4.7.  Mineral and vitamin supplements

4.7.1.  Market estimates and forecast, by region, 2013 - 2024

4.8.  Sleeping aids

4.8.1.  Market estimates and forecast, by region, 2013 - 2024

4.9.  Ophthalmic products

4.9.1.  Market estimates and forecast, by region, 2013 - 2024

4.10. Others

4.10.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5.    Over-the-counter (OTC) Drugs Market, By Region

5.1.  Over-the-counter (OTC) drugs market share, by region, 2016 & 2024

5.2.  North America

5.2.1.    Market estimates and forecast, by country, 2013 - 2024

5.2.2.    Market estimates and forecast, by product, 2013 - 2024

5.2.3.  U.S.

5.2.3.1.  Market estimates and forecast, by product, 2013 - 2024

5.2.4.  Canada

5.2.4.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.  Europe

5.3.1.    Market estimates and forecast, by country, 2013 - 2024

5.3.2.    Market estimates and forecast, by product, 2013 - 2024

5.3.3.  Germany

5.3.3.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.4.  UK

5.3.4.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.5.  France

5.3.5.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.6.  Italy

5.3.6.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.7.  Spain

5.3.7.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.8.  Russia

5.3.8.1.  Market estimates and forecast, by product, 2013 - 2024

5.3.9.  Poland

5.3.9.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.  Asia Pacific

5.4.1.    Market estimates and forecast, by country, 2013 - 2024

5.4.2.    Market estimates and forecast, by product, 2013 - 2024

5.4.3.  India

5.4.3.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.4.  China

5.4.4.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.5.  Japan

5.4.5.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.6.  Australia

5.4.6.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.7.  New Zealand

5.4.7.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.8.  South Korea

5.4.8.1.  Market estimates and forecast, by product, 2013 - 2024

5.4.9.  Taiwan

5.4.9.1.  Market estimates and forecast, by product, 2013 - 2024

5.5.  Latin America

5.5.1.    Market estimates and forecast, by country, 2013 - 2024

5.5.2.    Market estimates and forecast, by product, 2013 - 2024

5.5.3.  Mexico

5.5.3.1.  Market estimates and forecast, by product, 2013 - 2024

5.5.4.  Brazil

5.5.4.1.  Market estimates and forecast, by product, 2013 - 2024

5.5.5.  Argentina

5.5.5.1.  Market estimates and forecast, by product, 2013 - 2024

5.6.  Middle East and Africa

5.6.1.    Market estimates and forecast, by country, 2013 - 2024

5.6.2.    Market estimates and forecast, by product, 2013 - 2024

5.6.3.  South Africa

5.6.3.1.  Market estimates and forecast, by product, 2013 - 2024

5.6.4.  Saudi Arabia

5.6.4.1.  Market estimates and forecast, by product, 2013 - 2024

5.6.5.  Kuwait

5.6.5.1.  Market estimates and forecast, by product, 2013 - 2024

5.6.6.  Qatar

5.6.6.1.  Market estimates and forecast, by product, 2013 – 2024

Chapter 6.  Company Profiles

6.1.  Bayer HealthCare

6.1.1.  Business overview

6.1.2.  Financial data

6.1.3.  Product landscape

6.1.4.  Strategic outlook

6.1.5.  SWOT analysis

6.2.  GlaxoSmithKline (GSK)

6.2.1.  Business overview

6.2.2.  Financial data

6.2.3.  Product landscape

6.2.4.  Strategic outlook

6.2.5.  SWOT analysis

6.3.  Sanofi

6.3.1.  Business overview

6.3.2.  Financial data

6.3.3.  Product landscape

6.3.4.  Strategic outlook

6.3.5.  SWOT analysis

6.4.  Johnson & Johnson

6.4.1.  Business overview

6.4.2.  Financial data

6.4.3.  Product landscape

6.4.4.  Strategic outlook

6.4.5.  SWOT analysis

6.5.  Pfizer

6.5.1.  Business overview

6.5.2.  Financial data

6.5.3.  Product landscape

6.5.4.  Strategic outlook

6.5.5.  SWOT analysis

6.6.  Sun Pharmaceutical Industries Ltd.

6.6.1.  Business overview

6.6.2.  Financial data

6.6.3.  Product landscape

6.6.4.  Strategic outlook

6.6.5.  SWOT analysis

6.7.  Alkem Laboratories Limited

6.7.1.  Business overview

6.7.2.  Financial data

6.7.3.  Product landscape

6.7.4.  Strategic outlook

6.7.5.  SWOT analysis

6.8.  Cipla, Inc. 

6.8.1.  Business overview

6.8.2.  Financial data

6.8.3.  Product landscape

6.8.4.  Strategic outlook

6.8.5.  SWOT analysis

6.9.   Teva Pharmaceutical Industries Ltd.

6.9.1.  Business overview

6.9.2.  Financial data

6.9.3.  Product landscape

6.9.4.  Strategic outlook

6.9.5.  SWOT analysis

6.10.  Glenmark Pharmaceuticals Ltd.

6.10.1.  Business overview

6.10.2.  Financial data

6.10.3.  Product landscape

6.10.4.  Strategic outlook

6.10.5.  SWOT analysis

6.11.  Takeda

6.11.1.  Business overview

6.11.2.  Financial data

6.11.3.  Product landscape

6.11.4.  Strategic outlook

6.11.5.  SWOT analysis

6.12.  Innovus Pharmaceutical Inc.

6.12.1.  Business overview

6.12.2.  Financial data

6.12.3.  Product landscape

6.12.4.  Strategic outlook

6.12.5.  SWOT analysis

6.13.  Dr. Reddy's Laboratories

6.13.1.  Business overview

6.13.2.  Financial data

6.13.3.  Product landscape

6.13.4.  Strategic outlook

6.13.5.  SWOT analysis

6.14.  Reckitt Benckiser Group Plc

6.14.1.  Business overview

6.14.2.  Financial data

6.14.3.  Product landscape

6.14.4.  Strategic outlook

6.14.5.  SWOT analysis

6.15.  Piramal

6.15.1.  Business overview

6.15.2.  Financial data

6.15.3.  Product landscape

6.15.4.  Strategic outlook

6.15.5.  SWOT analysis

 

Data Tables

TABLE 1.    Over-the-counter (OTC) drugs industry 360° synopsis, 2013 – 2024    

TABLE 2.    Global Over-the-counter (OTC) drugs market, 2013-2016 (USD Million)

TABLE 3.    Global Over-the-counter (OTC)drugs market, by product,2013-2016(USD Million    

TABLE 4.    Global Over-the-counter (OTC) drugs market, by region, 2013-2016 (USD Million)

TABLE 5.    Industry impact forces

TABLE 6.    U.S. FDA prescription to over-the-counter (OTC) switch list    

TABLE 7.    Analgesics market, by region, 2013 – 2024 (USD Million)    

TABLE 8.    Cold, cough and flu market, by region, 2013 – 2024 (USD Million)

TABLE 9.    Weight loss market, by region, 2013 – 2024 (USD Million)    

TABLE 10.    Gastrointestinal market, by region, 2013 – 2024 (USD Million)    

TABLE 11.    Skin market, by region, 2013 – 2024 (USD Million)

TABLE 12.    Minerals and vitamins market, by region, 2013 – 2024 (USD Million)

TABLE 13.    Sleeping aids market, by region, 2013 – 2024 (USD Million)    

TABLE 14.    Ophthalmic market, by region, 2013 – 2024 (USD Million)    

TABLE 15.    Others market, by region, 2013 – 2024 (USD Million)        

TABLE 16.    North America Over-the-counter (OTC) drugs market, by country, 2013 – 2024 (USD Million)

TABLE 17.    North America Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 18.    U.S. Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 19.    Canada Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 20.    Europe Over-the-counter (OTC) drugs market, by country, 2013 – 2024 (USD Million)    

TABLE 21.    Europe Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 22.    Germany Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 23.    UK Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 24.    Italy Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 25.    France Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 26.    Spain Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 27.    Russia Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 28.    Poland Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 29.    Asia Pacific Over-the-counter (OTC) drugs market, by country, 2013 – 2024 (USD Million)

TABLE 30.    Asia Pacific Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 31.    China Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 32.    India Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 33.    Japan Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 34.    Australia Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 35.    South Korea Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 36.    Taiwan Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 37.    Latin America Over-the-counter (OTC) drugs market, by country, 2013 – 2024 (USD Million)

TABLE 38.    Latin America Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 39.    Brazil Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 40.    Mexico Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 41.    Argentina Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)    

TABLE 42.    MEA Over-the-counter (OTC) drugs market, by country, 2013 – 2024 (USD Million)

TABLE 43.    MEA Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 44.    South Africa Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 45.    Saudi Arabia Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 46.    Kuwait Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)

TABLE 47.    Qatar Over-the-counter (OTC) drugs market, by product, 2013 – 2024 (USD Million)
 

 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global Over-the-counter (OTC) drugs market, 2013- 2024 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Porter’s analysis

FIG. 5    PESTEL analysis

FIG. 6    Strategy dashboard

FIG. 7    Over-the-counter (OTC) drugs market share, by product, 2016 & 2024

FIG. 8    Over-the-counter (OTC) drugs market share, by region, 2016 & 2024

 

 

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security

Tailor this report

Customize this report to suit your needs, speak to our research team to avail these benefits


Connect with our sales team